Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer
NAGIOS: RODERIC FUNCIONANDO

Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer

DSpace Repository

Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer

Show simple item record

dc.contributor.author Hayashi, Naoki es_ES
dc.contributor.author Iwamoto, Takayuki es_ES
dc.contributor.author González-Angulo, Ana María es_ES
dc.contributor.author Ferrer-Lozano, Jaime es_ES
dc.contributor.author Lluch Hernández, Ana es_ES
dc.contributor.author Niikura, Naoki es_ES
dc.contributor.author Bartholomeusz, Chandra es_ES
dc.contributor.author Nakamura, Seigo es_ES
dc.contributor.author Hortobagyi, Gabriel N. es_ES
dc.contributor.author Ueno, Naoto T. es_ES
dc.date.accessioned 2015-06-22T09:50:06Z
dc.date.available 2015-06-22T09:50:06Z
dc.date.issued 2011 es_ES
dc.identifier.uri http://hdl.handle.net/10550/44664
dc.description.abstract The prognostic value of the expression level of tyrosine 1248–phosphorylated human epidermal growth factor receptor (HER)-2 in patients with HER-2+ primary breast cancer is examined. es_ES
dc.source The Oncologist Vol. 16 Issue 7: pp. 956-965 es_ES
dc.subject Breast cancer es_ES
dc.subject HER-2 es_ES
dc.subject Reverse-phase protein array es_ES
dc.subject Metastases es_ES
dc.subject Phosphorylation es_ES
dc.title Prognostic Impact of Phosphorylated HER-2 in HER-2+ Primary Breast Cancer es_ES
dc.type info:eu-repo/semantics/article es_ES
dc.identifier.doi 10.1634/theoncologist.2010-0409 es_ES
dc.identifier.idgrec 070444 es_ES

View       (855.1Kb)

This item appears in the following Collection(s)

Show simple item record

Search DSpace

Advanced Search

Browse

Statistics